Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,072 JPY | -1.75% | -2.40% | +18.40% |
2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Sales 2024 | 129B 824M | Sales 2025 * | 142B 902M | Capitalization | 19.63B 125M |
---|---|---|---|---|---|
Net income 2024 | 1.6B 10.16M | Net income 2025 * | 2.01B 12.83M | EV / Sales 2024 | 0.15 x |
Net Debt 2024 * | 6.08B 38.72M | Net Debt 2025 * | 4.38B 27.87M | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 |
12
x | P/E ratio 2025 * |
9.69
x | Employees | 1,592 |
Yield 2024 |
2.46% | Yield 2025 * |
2.53% | Free-Float | 21.93% |
1 day | -1.75% | ||
1 week | -2.40% | ||
Current month | -5.90% | ||
1 month | -3.13% | ||
3 months | +11.16% | ||
6 months | +7.75% | ||
Current year | +18.40% |
Managers | Title | Age | Since |
---|---|---|---|
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 09-11-30 |
Hiroyuki Maegaki
DFI | Director of Finance/CFO | - | 02-09-30 |
Junichi Sato
CHM | Chairman | 65 | 81-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takayuki Oshima
BRD | Director/Board Member | 69 | 21-06-24 |
Junichi Sato
CHM | Chairman | 65 | 81-02-28 |
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 09-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2,072 | -1.75% | 2,700 |
24-05-23 | 2,109 | -1.17% | 4,400 |
24-05-22 | 2,134 | +1.38% | 4,800 |
24-05-21 | 2,105 | -1.27% | 4,300 |
24-05-20 | 2,132 | +0.42% | 2,800 |
Delayed Quote Japan Exchange, May 24, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.40% | 125M | |
-5.95% | 5.82B | |
-6.07% | 967M | |
+11.49% | 412M | |
+1.31% | 213M | |
-21.83% | 171M | |
+16.62% | 109M | |
-13.82% | 65.53M | |
+11.82% | 58.01M | |
-26.67% | 52.19M |
- Stock Market
- Equities
- 7686 Stock